The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology's Annual Scientific ...

Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...

FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of ...

The U.S. food industry is firmly opposing Robert F. Kennedy Jr.’s aggressive effort to eliminate artificial dyes, following his March 10 meeting with ...

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

Dr. Marty Makary — a surgeon, author and researcher — lauded the FDA’s “gold-standard science” in testimony before the Senate’s health committee, which will vote on whether to advance ...

President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency ...

A confirmation vote by the full Senate is expected later this month. The FDA has long been a target for Kennedy, who last year vowed to “clear out” entire departments at the agency ...